NFIB and adrenal cortex carcinoma: However, Drier et al. examined the genomic loci translocated to MYB in patients suffering from ACC and identified several super-enhancers in the rearranged portion of NFIB, which is able to interact with the MYB promoter, causing its overexpression [22].